Living Systematic Review of Therapeutic Options for Post Acute or Post COVID-19 Condition
Fecha
2023Número de documento
PAHO/IMS/EIH/COVID-19/23-0006
Metadatos
Mostrar el registro completo del ítemResumen
This review compiles the evidence on potential therapeutic options for post-COVID-19 conditions (PCC). Included are all the identified clinical forms, symptoms, and manifestations of PCC for which an intervention was assessed in at least one randomized controlled trial.
Colecciones
Esta leyenda debe conservarse, junto con la URL original del artículo.Attribution-NonCommercial-ShareAlike 3.0 IGO
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Pan American Health Organization; Evidence and Intelligence for Action in Health (EIH) (PAHOUnited StatesWashington, D.C., 2020)Take home message thus far: • We examined 24 therapeutic options thus far; currently, there is no evidence of any important benefit from any therapeutic option (though remdesivir is revealing promise as one option based ...
-
Pan American Health Organization; Evidence and Intelligence for Action in Health (EIH) (PAHOUnited StatesWashington, D.C., 2020)More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, we have examined 40 therapeutic options. The Pan American Health Organization (PAHO) is ...
-
Pan American Health Organization; Evidence and Intelligence for Action in Health (EIH) (PAHOUnited StatesWashington, D.C., 2020)More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, we examined 30 therapeutic options.